AU5971300A - Rheumatic autoimmune disease antigen - Google Patents

Rheumatic autoimmune disease antigen

Info

Publication number
AU5971300A
AU5971300A AU59713/00A AU5971300A AU5971300A AU 5971300 A AU5971300 A AU 5971300A AU 59713/00 A AU59713/00 A AU 59713/00A AU 5971300 A AU5971300 A AU 5971300A AU 5971300 A AU5971300 A AU 5971300A
Authority
AU
Australia
Prior art keywords
autoimmune disease
disease antigen
rheumatic autoimmune
rheumatic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59713/00A
Inventor
Peter Prehm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99110895A external-priority patent/EP1059087A1/en
Application filed by Individual filed Critical Individual
Publication of AU5971300A publication Critical patent/AU5971300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59713/00A 1999-06-08 2000-06-07 Rheumatic autoimmune disease antigen Abandoned AU5971300A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP99110895A EP1059087A1 (en) 1999-06-08 1999-06-08 Antigens from rheumatoid autoimmune diseases
EP99110895 1999-06-08
DE19947520 1999-10-02
DE19947520 1999-10-02
DE19950462 1999-10-20
DE19950462 1999-10-20
PCT/EP2000/005279 WO2000074705A1 (en) 1999-06-08 2000-06-07 Rheumatic autoimmune disease antigen

Publications (1)

Publication Number Publication Date
AU5971300A true AU5971300A (en) 2000-12-28

Family

ID=27219307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59713/00A Abandoned AU5971300A (en) 1999-06-08 2000-06-07 Rheumatic autoimmune disease antigen

Country Status (2)

Country Link
AU (1) AU5971300A (en)
WO (1) WO2000074705A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1317426T3 (en) 2000-09-14 2006-01-09 Gruenenthal Gmbh Pay-thio-amino acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3555691B2 (en) * 1993-12-03 2004-08-18 生化学工業株式会社 Hyaluronan binding protein and antibody from human synovial fluid
JP3976848B2 (en) * 1996-07-16 2007-09-19 生化学工業株式会社 Method and kit for measuring serum-derived hyaluronan binding protein-hyaluronic acid conjugate
JP3702382B2 (en) * 1997-10-22 2005-10-05 参天製薬株式会社 NF-κB activation inhibitor

Also Published As

Publication number Publication date
WO2000074705A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU1951201A (en) Peptide antigens
AU4935000A (en) Antibodies
AU2971000A (en) Mechanical fastener
AU8154798A (en) Disease associated protein kinases
AU5095000A (en) Receptor interacting protein rip3
AU6045900A (en) Interaction-activated proteins
AU1229101A (en) Cervical immobilization
AU2001290860A1 (en) Spas-1 cancer antigen
AU5441000A (en) Human monoclonal antibody
AU9512498A (en) Portable shampoo bowl
AU1608201A (en) Human zven proteins
AU2977500A (en) Advanced antigen presentation platform
AU3838400A (en) Processor
AU3283500A (en) Tumor-associated antigen
AU2452301A (en) Protein methylarginine-specific antibodies
AU3988100A (en) Processor
AU2085401A (en) Ultrasonic standard
AU5971300A (en) Rheumatic autoimmune disease antigen
AU4553100A (en) Tumour-associated antigen
AU4456800A (en) Human hac3
AU7788600A (en) Colon-tumour-associated antigens
AU1540701A (en) Novel protein
GB9915419D0 (en) Antigens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase